The largest database of trusted experimental protocols

4 protocols using adar1 antibody

1

Western Blot Analysis of Hepatocyte Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein lysate was extracted from hepatocytes and liver tissue using lysis buffer (Cell Signaling Technology) and western blotting as previously described6 (link). P38, phospho-P38, ERK, phospho-ERK, JNK, phospho-JNK, caspase 3, cleaved caspase 3, BCL-2, IRF1, and RIG-I were purchased from Cell Signaling Technology; ADAR1 antibody was purchased from Santa Cruz (cat# SC73408, clone 15.8.6). Secondary antibodies were purchased from Promega.
+ Open protocol
+ Expand
2

Knockdown of ADAR, FMRP, FXR1P, and FXR2 in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLKO1 non-target control-shRNA (SHC016), FMR1-targeting shRNA (TRCN0000059758) or FXR1-targeting shRNA (TRCN0000159153) constructs were used. We produced lentiviruses via co-transfection of pCMV-d8.91, pVSV-G and pLKO1 into HEK293T cells using Lipofectamine 3000 (Thermo Fisher Scientific, L3000015). Transduction was carried out according to the standard protocol of the ENCODE consortium62 (link). Briefly, viruses were collected from conditioned media after 48 h co-transfection. Lentivirus-containing media was mixed with the same volume of DMEM media that contain polybrene (8 μg/ml), which was used to infect HeLa, SK-N-BE(2), and KELLY cells. After 24 h, cells were incubated with puromycin (2 μg/ml for HeLa and 1 μg/ml for SK-N-BE(2) and KELLY) for 3–7 days. Knockdown efficiency was evaluated by Western blot. Cells were lysed in RIPA containing complete protease inhibitor cocktail. Cell lysates were then resolved through 8% SDS-PAGE and probed by ADAR1 antibody (Santa Cruz, sc-271854), ADAR2 antibody (Santa Cruz, sc-73409), FMRP antibody (Millipore, MAB2160), FXR1P antibody (Bethyl Laboratories, A303–892A), and FXR2 antibody (Sigma-Aldrich, F1554).
+ Open protocol
+ Expand
3

Knockdown of ADAR, FMRP, FXR1P, and FXR2 in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLKO1 non-target control-shRNA (SHC016), FMR1-targeting shRNA (TRCN0000059758) or FXR1-targeting shRNA (TRCN0000159153) constructs were used. We produced lentiviruses via co-transfection of pCMV-d8.91, pVSV-G and pLKO1 into HEK293T cells using Lipofectamine 3000 (Thermo Fisher Scientific, L3000015). Transduction was carried out according to the standard protocol of the ENCODE consortium62 (link). Briefly, viruses were collected from conditioned media after 48 h co-transfection. Lentivirus-containing media was mixed with the same volume of DMEM media that contain polybrene (8 μg/ml), which was used to infect HeLa, SK-N-BE(2), and KELLY cells. After 24 h, cells were incubated with puromycin (2 μg/ml for HeLa and 1 μg/ml for SK-N-BE(2) and KELLY) for 3–7 days. Knockdown efficiency was evaluated by Western blot. Cells were lysed in RIPA containing complete protease inhibitor cocktail. Cell lysates were then resolved through 8% SDS-PAGE and probed by ADAR1 antibody (Santa Cruz, sc-271854), ADAR2 antibody (Santa Cruz, sc-73409), FMRP antibody (Millipore, MAB2160), FXR1P antibody (Bethyl Laboratories, A303–892A), and FXR2 antibody (Sigma-Aldrich, F1554).
+ Open protocol
+ Expand
4

DROSHA Immunoprecipitation and Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were maintained with DMEM supplemented with 10% FBS and 100 U mL−1 penicillin/streptomycin at 37 °C and 5% CO2. Ten million cells were collected and lysed in 1 mL non-denaturing lysis buffer at pH 8.0, containing 20 mM Tris-HCl, 125 mM NaCl, 1% NP-40, and 2 mM EDTA supplemented with complete protease inhibitor cocktail. Extracted proteins were incubated overnight with DROSHA antibody (Bethyl Laboratories, A301-886A) at 4 °C; precipitation of the immune complexes was performed with Dynabeads Protein G (Thermo Fisher Scientific, 1003D) for 4 h at 4 °C, according to the manufacturer’s instructions. After immunoprecipitation, the beads were washed three times with the lysis buffer at 4 °C and eluted from the Dynabeads using elute buffer (0.2 M glycine, at pH 2.8). Twenty microliters were loaded onto the gel and the samples were processed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by Western blot. The following antibodies were used for the Western blots: ADAR1 antibody (Santa Cruz, sc-73408) and DROSHA antibody (Bethyl Laboratories, A301-886A). The HRP-linked secondary antibodies were used and the blots were visualized with the ECL kit (GE, RPN2232).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!